Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients

Sarah A. Imam, Mary K. Guyton, Azizul Haque, Arthur Vandenbark, William R. Tyor, Swapan K. Ray, Naren L. Banik

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Multiple sclerosis (MS) is a devastating autoimmune demyelinating disease of the central nervous system (CNS). This study investigated whether expression and activity of the calcium-activated protease calpain correlated with Th1/Th2 dysregulation in MS patients during states of relapse and remission. Calpain expression and activity were significantly increased in peripheral blood mononuclear cells (PBMCs) from MS patients, compared to controls, with the highest expression and activity noted during relapse. Th1 cytokines were highest and Th2 cytokines were lowest in MS patients during relapse. Treatment with calpain inhibitor, calpeptin, decreased Th1 cytokines in PBMCs from MS patients. Calpain inhibitor also reduced degradation of myelin basic protein (MBP) by inhibiting the calpain secreted from MBP-specific T cells. Taken together, these results suggested calpain involvement in Th1/Th2 dysregulation in MS patients.

Original languageEnglish (US)
Pages (from-to)139-145
Number of pages7
JournalJournal of Neuroimmunology
Volume190
Issue number1-2
DOIs
StatePublished - Oct 2007

Fingerprint

Calpain
Multiple Sclerosis
Blood Cells
Cytokines
Myelin Basic Protein
Recurrence
CNS Demyelinating Autoimmune Diseases
T-Lymphocytes

Keywords

  • Calpain
  • Cytokines
  • Multiple sclerosis
  • T cell activation
  • Th1/Th2 dysregulation

ASJC Scopus subject areas

  • Immunology
  • Clinical Neurology
  • Immunology and Allergy
  • Neurology

Cite this

Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients. / Imam, Sarah A.; Guyton, Mary K.; Haque, Azizul; Vandenbark, Arthur; Tyor, William R.; Ray, Swapan K.; Banik, Naren L.

In: Journal of Neuroimmunology, Vol. 190, No. 1-2, 10.2007, p. 139-145.

Research output: Contribution to journalArticle

Imam, Sarah A. ; Guyton, Mary K. ; Haque, Azizul ; Vandenbark, Arthur ; Tyor, William R. ; Ray, Swapan K. ; Banik, Naren L. / Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients. In: Journal of Neuroimmunology. 2007 ; Vol. 190, No. 1-2. pp. 139-145.
@article{546d5a9f1bf1467291280302c6798574,
title = "Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients",
abstract = "Multiple sclerosis (MS) is a devastating autoimmune demyelinating disease of the central nervous system (CNS). This study investigated whether expression and activity of the calcium-activated protease calpain correlated with Th1/Th2 dysregulation in MS patients during states of relapse and remission. Calpain expression and activity were significantly increased in peripheral blood mononuclear cells (PBMCs) from MS patients, compared to controls, with the highest expression and activity noted during relapse. Th1 cytokines were highest and Th2 cytokines were lowest in MS patients during relapse. Treatment with calpain inhibitor, calpeptin, decreased Th1 cytokines in PBMCs from MS patients. Calpain inhibitor also reduced degradation of myelin basic protein (MBP) by inhibiting the calpain secreted from MBP-specific T cells. Taken together, these results suggested calpain involvement in Th1/Th2 dysregulation in MS patients.",
keywords = "Calpain, Cytokines, Multiple sclerosis, T cell activation, Th1/Th2 dysregulation",
author = "Imam, {Sarah A.} and Guyton, {Mary K.} and Azizul Haque and Arthur Vandenbark and Tyor, {William R.} and Ray, {Swapan K.} and Banik, {Naren L.}",
year = "2007",
month = "10",
doi = "10.1016/j.jneuroim.2007.07.016",
language = "English (US)",
volume = "190",
pages = "139--145",
journal = "Journal of Neuroimmunology",
issn = "0165-5728",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Increased calpain correlates with Th1 cytokine profile in PBMCs from MS patients

AU - Imam, Sarah A.

AU - Guyton, Mary K.

AU - Haque, Azizul

AU - Vandenbark, Arthur

AU - Tyor, William R.

AU - Ray, Swapan K.

AU - Banik, Naren L.

PY - 2007/10

Y1 - 2007/10

N2 - Multiple sclerosis (MS) is a devastating autoimmune demyelinating disease of the central nervous system (CNS). This study investigated whether expression and activity of the calcium-activated protease calpain correlated with Th1/Th2 dysregulation in MS patients during states of relapse and remission. Calpain expression and activity were significantly increased in peripheral blood mononuclear cells (PBMCs) from MS patients, compared to controls, with the highest expression and activity noted during relapse. Th1 cytokines were highest and Th2 cytokines were lowest in MS patients during relapse. Treatment with calpain inhibitor, calpeptin, decreased Th1 cytokines in PBMCs from MS patients. Calpain inhibitor also reduced degradation of myelin basic protein (MBP) by inhibiting the calpain secreted from MBP-specific T cells. Taken together, these results suggested calpain involvement in Th1/Th2 dysregulation in MS patients.

AB - Multiple sclerosis (MS) is a devastating autoimmune demyelinating disease of the central nervous system (CNS). This study investigated whether expression and activity of the calcium-activated protease calpain correlated with Th1/Th2 dysregulation in MS patients during states of relapse and remission. Calpain expression and activity were significantly increased in peripheral blood mononuclear cells (PBMCs) from MS patients, compared to controls, with the highest expression and activity noted during relapse. Th1 cytokines were highest and Th2 cytokines were lowest in MS patients during relapse. Treatment with calpain inhibitor, calpeptin, decreased Th1 cytokines in PBMCs from MS patients. Calpain inhibitor also reduced degradation of myelin basic protein (MBP) by inhibiting the calpain secreted from MBP-specific T cells. Taken together, these results suggested calpain involvement in Th1/Th2 dysregulation in MS patients.

KW - Calpain

KW - Cytokines

KW - Multiple sclerosis

KW - T cell activation

KW - Th1/Th2 dysregulation

UR - http://www.scopus.com/inward/record.url?scp=35448961570&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35448961570&partnerID=8YFLogxK

U2 - 10.1016/j.jneuroim.2007.07.016

DO - 10.1016/j.jneuroim.2007.07.016

M3 - Article

VL - 190

SP - 139

EP - 145

JO - Journal of Neuroimmunology

JF - Journal of Neuroimmunology

SN - 0165-5728

IS - 1-2

ER -